Market Opens

Rohit Mehta, President and Chief Executive Officer, Global X Investments Canada Inc. (“Global X”) joined Graham MacKenzie, Managing Director, Exchange Traded Products, Toronto Stock Exchange (“TSX”), to close the market and celebrate the launch of their six PowerStock ETFs: Global X Alphabet PowerStock ETF (TSX: GOOP), Global X Amazon PowerStock ETF (TSX: AMZP), Global X Apple PowerStock ETF (TSX: AAPP), Global X NVIDIA PowerStock ETF (TSX: NVDP), Global X SpaceX PowerStock ETF (TSX: SPCP), Global X Tesla PowerStock ETF (TSX: TSLP). The PowerStock ETFs is a new suite of lightly-leveraged single-stock ETFs designed to give Canadians enhanced exposure to individual companies without the need for margin. The initial lineup offers enhanced exposure to Alphabet, Amazon, Apple, NVIDIA, SpaceX and Tesla. Each of the PowerStock ETFs seek to provide long-term capital appreciation by targeting 33% additional exposure to its underlying stock – approximately $133 of stock exposure for every $100 invested. The ETFs trade in Canadian dollars and hedge foreign currency exposure back to the Canadian dollar. Global X Investments Canada Inc. is an innovative financial services company and offers one of the largest suites of exchange traded funds in Canada. The Global X Fund family includes a broadly diversified range of solutions for investors of all experience levels to meet their investment objectives in a variety of market conditions. Global X has over $58 billion of assets under management and more than 160 ETFs listed on major Canadian stock exchanges. Global X is a wholly-owned subsidiary of the Mirae Asset Financial Group, which manages more than $1 trillion of assets across 21 countries and global markets around the world.

Martin Felton, Vice-President, National Sales, National Bank Investments Inc. (“National Bank Investments” or “NBI”), and members of his team, joined Graham MacKenzie, Managing Director, Exchange Traded Products, Toronto Stock Exchange (“TSX”), to open the market and celebrate the launch of their ETF Portfolios, Thematic Rotation ETF and new ETF series of their SmartData Funds: NBI Balanced ETF Portfolio (TSX: NBLD), NBI Conservative ETF Portfolio (TSX: NCNS), NBI Equity ETF Portfolio (TSX: NEQT), NBI Growth ETF Portfolio (TSX: NGRW), NBI Thematic Rotation ETF (TSX: NTHM), NBI SmartData International Equity Covered Call Fund (TSX: NICC), NBI SmartData U.S. Equity Covered Call Fund (TSX: NUCC), NBI SmartData Enhanced Yield U.S. Equity Fund (TSX: NSUY), NBI SmartData Canadian Equity Fund (TSX: NSDC), NBI Target 2032 Investment Grade Bond Fund (TSX: NTGG), NBI Ultra Short-Term Fixed Income Fund (TSX: NUST). NBI is an investment fund management firm committed to manufacturing and offering mutual funds, investment solutions and services designed to help Canadian investors pursue their financial goals. As at June 30, 2026, assets under management in NBI products were valued at over $128 billion. Guided by an open architecture strategy, NBI is dedicated to providing diverse solutions to meet the evolving needs of its clients. NBI consistently strives to be recognized as a key partner by combining innovation and excellence. NBI’s role is not limited to administrative aspects of management; NBI Advisory Services and its registered representatives form a team of specialists who provide information and advice to help advisors build portfolios adapted to their clients’ financial needs. Follow NBI’s activities at nbinvestments.ca. NBI is a signatory of the United Nations-supported Principles for Responsible Investment, a member of Canada’s Responsible Investment Association, and a founding participant in the Climate Engagement Canada initiative.

Dr. Christine Brezden-Masley, Director of the Marvelle Koffler Breast Centre and the Medical Director of the Cancer Program at Mount Sinai Hospital (“Mount Sinai” or the “Hospital”), and he team, joined Michael Landa, Head of Internal Audit, TMX Group, to close the market to promote an internationally recognized breast cancer leader, Dr. Eric Winer, who will be educating the staff at Mount Sinai and UHN on his research and field of expertise. Mount Sinai Hospital, part of Sinai Health, is an internationally recognized acute care academic health science centre affiliated with the University of Toronto. The Hospital is a leader in the clinical areas of women’s and infants’ health, chronic disease management, specialized cancer care, emergency medicine, and geriatrics. Founded in 1923, Mount Sinai is committed to the service of others and its purpose to care, create possibilities and offer hope. The Jennifer Landa Breast Cancer Visiting Professorship was established in 2017 by the late Jennifer Landa, a former young breast cancer patient at the Marvelle Koffler Breast Centre, whose goal was to bring international breast cancer leaders to Mount Sinai Hospital and University Health Network to enhance and expand the knowledge base of our multi-disciplinary team, and health-care professionals across Toronto.

Kerry James, Head of Client Relations and Portfolio Specialist, Counterpoint Global, David Stephenson, Director, ETF Product Development, CIBC Global Asset Management (“CIBC GAM” or the “Company”) and their teams, joined Graham MacKenzie, Managing Director, Exchange Traded Products, Toronto Stock Exchange (“TSX”), to open the market and celebrate launch of the Company’s four high-conviction, actively managed Counterpoint Global CIBC ETFs: Counterpoint Global CIBC Global Permanence ETF (TSX: CCGP), Counterpoint Global CIBC International Permanence ETF (TSX: CCIP), Counterpoint Global CIBC U.S. Large Cap Growth ETF (TSX: CCUL), Counterpoint Global CIBC U.S. Small Cap Growth ETF (TSX: CCUS). CCGP applies an active management approach with bottom-up stock selection, emphasizing companies with strong name recognition, durable competitive advantages, and attractive risk/reward profiles. CCIP offers a bottom-up fundamental investment process, targeting companies with sustainable competitive advantages, strong balance sheets, and above average business visibility. CCUL offers investors access to a portfolio of leading large-cap U.S. companies, selectively chosen for their strong growth potential and attractive valuations. CCUS focuses on small-cap US companies, offering access to a segment often associated with higher growth potential and greater volatility. These products mark the launch of the Counterpoint Global CIBC ETFs suite. For more information on the Company’s complete ETF lineup, please visit: cibc.com/etfs.